✦ LIBER ✦

FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program

✍ Scribed by Thierry Poynard; Mona Munteanu; Massimo Colombo; Jordi Bruix; Eugene Schiff; Ruben Terg; Steven Flamm; Ricardo Moreno-Otero; Flair Carrilho; Warren Schmidt; Thomas Berg; Thomas Mcgarrity; E. Jenny Heathcote; Fernando Gonçales; Moises Diago; Antonio Craxi; Marcelo Silva; Navdeep Boparai; Louis Griffel; Margaret Burroughs; Clifford Brass; Janice Albrecht

Book ID: 116652236
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 994 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2010.06.038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to: “FibroTest is an indepen

Corrigendum to: “FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program” [J Hepatol 2011;54:227–235]

✍ Poynard, Thierry; Munteanu, Mona; Colombo, Massimo; Bruix, Jordi; Schiff, Eugene 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 148 KB

831 FibroTest (Ft) Baseline Value Is An

831 FibroTest (Ft) Baseline Value Is An Independent Predictor of Early (EVR) and Sustained Virological Response (SVR) in Non-Responders Patients Re-Treated with Pegylated Interferon Alfa-2B (PEG-2B) and Ribavirin in EPIC3

✍ Poynard, Thierry; Schiff, Eugene R.; Terg, Ruben; Moreno-Otero, Ricardo; Flamm, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 88 KB

413 FIBROTEST (FT) VALUE INDEPENDENTLY P

413 FIBROTEST (FT) VALUE INDEPENDENTLY PREDICTS EARLY (EVR) AND SUSTAINED VIROLOGICAL RESPONSE (SVR) IN NON-RESPONDER PATIENTS RE-TREATED WITH PEGYLATED INTERFERON ALFA-2B (PEG-2B) AND RIBAVIRIN IN EPIC3

✍ T. Poynard; E.R. Schiff; R. Terg; R. Moreno-Otero; S.L. Flamm; W. Schmidt; T. Be 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Pegylated interferon alpha-2b plus ribav

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response

✍ Sanaa M. Kamal; Samer S. El Kamary; Michelle D. Shardell; Mohamed Hashem; Imad N 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated

[573] COMPARISON OF EARLY VIROLOGIC RESP

[573] COMPARISON OF EARLY VIROLOGIC RESPONSE AMONG PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH GENOTYPE NON 2/3 TREATED WITH PEGYLATED INTERFERON ALFA-2b AND RIBAVIRIN IN DEPENDENCE WITH HEPATIC FIBROSIS STAGES

✍ H. Berak; A. Kolakowska-Rzadzka; M. Wasilewski; J. Kowalska; I. Stanczak; K. Bar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Rapid virological response tailors the d

Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin in Pakistan

✍ Gill, Uzma; Aziz, Hafsa; Gill, Muzaffar Lateef 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 460 KB